-transparent.png){kind=logo}
The characteristics of motor function and brain dopamine (DA) metabolism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice after immersion immobilization stress were investigated. There was no significant difference in locomotor activities between MPTP-treated and saline-treated mice, but locomotor activities of MPTP-treated mice after stress decreased more remarkably than those of saline-treated mice. Immediately after stress, striatal DA concentrations of MPTP-treated mice were significantly lower than those of saline-treated mice. Striatal DA levels improved when 24 h passed after stress. The striatal and cortical (DOPAC + HVA)/DA ratios of MPTP-and stress-treated mice was significantly higher than that of saline-and stress-treated mice. It is due to the decreased DA level and the enhancement of DA turnover that MPTP-treated mice became remarkably akinetic after stress, and that L-DOPA therapy is not effective when the symptoms in patients with Parkinson's disease worsen due to stress.
K Urakami, and
N Masaki, and
K Shimoda, and
S Nishikawa, and
K Takahashi
May 1993,
Neurochemical research,
K Urakami, and
N Masaki, and
K Shimoda, and
S Nishikawa, and
K Takahashi
August 1986,
Research communications in chemical pathology and pharmacology,
K Urakami, and
N Masaki, and
K Shimoda, and
S Nishikawa, and
K Takahashi
September 1978,
Life sciences,
K Urakami, and
N Masaki, and
K Shimoda, and
S Nishikawa, and
K Takahashi
January 1995,
Progress in brain research,
K Urakami, and
N Masaki, and
K Shimoda, and
S Nishikawa, and
K Takahashi
June 2000,
Neurotoxicology,
K Urakami, and
N Masaki, and
K Shimoda, and
S Nishikawa, and
K Takahashi
January 2016,
PloS one,
K Urakami, and
N Masaki, and
K Shimoda, and
S Nishikawa, and
K Takahashi
November 2017,
Brain research,
K Urakami, and
N Masaki, and
K Shimoda, and
S Nishikawa, and
K Takahashi
January 1991,
Proceedings of the Western Pharmacology Society,
K Urakami, and
N Masaki, and
K Shimoda, and
S Nishikawa, and
K Takahashi
February 2008,
Synapse (New York, N.Y.),
K Urakami, and
N Masaki, and
K Shimoda, and
S Nishikawa, and
K Takahashi
June 1993,
European journal of pharmacology,
